Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: GENENTECH USA, INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2025-09-26 to 2027-09-29
Current total value of award: $74970000
Description: PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS